Cure My Disease

Don't miss your cure!

 Log in / Sign up

New PET tracer could sharpen detection of lung cancer brain metastases

NCT ID NCT05452005

Recruiting now Diagnosis Sponsor: University of California, Davis Source: ClinicalTrials.gov ↗

First seen Feb 28, 2026 · Last updated May 01, 2026 · Updated 9 times

Summary

This early-phase study is testing a new radioactive imaging agent called [18F]-αvβ6-BP to see if it can better detect and monitor non-small cell lung cancer that has spread to the brain. About 20 adults with this type of lung cancer and brain metastases will receive a PET/CT scan using the new agent. The goal is to compare the new scan with standard imaging methods to improve how doctors stage the disease and choose treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The University of California Davis Comprehensive Cancer Center

    RECRUITING

    Sacramento, California, 95817, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.

BRAIN METASTASES LUNG CANCER LUNG CANCER METASTATIC NON SMALL CELL LUNG CANCER NON SMALL CELL LUNG CANCER